Besides or in combination with the antiatherogenic and antioxidative properties of apoA‐IV [16, 21], recombinant apoA‐IV stabilises the atherosclerosis plaque in the apoE‐knockout C57BL/6 mice and prevents acute plaque disruption [17]. The gene discussed is APOA4; the disease is atherosclerosis.